# BEYFORTUS

NDC: 49281-574
Generic name: nirsevimab
Labeler / Manufacturer: Sanofi Vaccines US Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20230718

FDA application: BLA761328

## Active ingredients

- NIRSEVIMAB: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49281-574"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49281-574
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f08fa60-f674-432d-801b-1f9514bd9b39